Anthrax Lethal Factor
From Proteopedia
(Difference between revisions)
(5 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <StructureSection load='1j7n' size=' | + | <StructureSection load='1j7n' size='340' side='right' scene='' caption='Anthrax toxin lethal factor dimer complex with sulfate and Zn+2 ions (grey) [[1j7n]]'> |
__TOC__ | __TOC__ | ||
==Introduction== | ==Introduction== | ||
---------------- | ---------------- | ||
- | '''Anthrax Lethal Factor''' (LF) is one of the enzymatic components belonging to the [http://en.wikipedia.org/wiki/Anthrax_toxin Anthrax Toxin]. Anthrax toxin is a three component exotoxin secreted by the bacterium [http://en.wikipedia.org/wiki/Bacillus_anthracis ''Bacillus Anthracis''] made up of a binding protein, protective antigen (PA) and two enzyme components edema factor (EF) and lethal factor (LF). <ref name=Collier>PMID: 14570563</ref> See also [[Toxins]]. | + | '''Anthrax Lethal Factor''' (LF) is one of the enzymatic components belonging to the [http://en.wikipedia.org/wiki/Anthrax_toxin Anthrax Toxin]. Anthrax toxin is a three component exotoxin secreted by the bacterium [http://en.wikipedia.org/wiki/Bacillus_anthracis ''Bacillus Anthracis''] made up of a binding protein, [[Anthrax protective antigen|protective antigen]] (PA) and two enzyme components [[Anthrax edema factor|edema factor]] (EF) and lethal factor (LF). <ref name=Collier>PMID: 14570563</ref> See also [[Toxins]]. |
Anthrax Toxin, encoded by plasmid pXO1, is considered an AB toxin, with two A domains (EF and LF) and one B domain (PA). <ref name=Collier>PMID: 14570563</ref> <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> On their own, these three domains are nontoxic, but any combination involving PA with EF and/or LF is what causes the physiological effects. <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref> Initially PA is a 83kDa protein which binds to the host Anthrax toxin Receptor (ATR). Upon binding, PA is cleaved into two fragments by furin proteases to become a 63 kDa protein bound to the ATR. Cleavage of PA allows self association to occur which forms a ring shaped heptamer know as the pore precursor (prepore). The prepore is now able to bind up to three molecules of EF and/or LF, leading to endocytosis of the complex. In the endosome, the prepore converts to a transmembrane pore, allowing translocation of EF and LF to the cytosol of target cell through a mechanism that is not well understood. EF and LF are now able to carry out their enzymatic activity on the host cell. <ref name=Collier>PMID: 14570563</ref> | Anthrax Toxin, encoded by plasmid pXO1, is considered an AB toxin, with two A domains (EF and LF) and one B domain (PA). <ref name=Collier>PMID: 14570563</ref> <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> On their own, these three domains are nontoxic, but any combination involving PA with EF and/or LF is what causes the physiological effects. <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref> Initially PA is a 83kDa protein which binds to the host Anthrax toxin Receptor (ATR). Upon binding, PA is cleaved into two fragments by furin proteases to become a 63 kDa protein bound to the ATR. Cleavage of PA allows self association to occur which forms a ring shaped heptamer know as the pore precursor (prepore). The prepore is now able to bind up to three molecules of EF and/or LF, leading to endocytosis of the complex. In the endosome, the prepore converts to a transmembrane pore, allowing translocation of EF and LF to the cytosol of target cell through a mechanism that is not well understood. EF and LF are now able to carry out their enzymatic activity on the host cell. <ref name=Collier>PMID: 14570563</ref> | ||
Line 23: | Line 23: | ||
PA+LF+EF Leads to lethal activity and edema | PA+LF+EF Leads to lethal activity and edema | ||
+ | |||
+ | See also [[Anthrax Lethal Factor (hebrew)]]. | ||
==Human Interaction== | ==Human Interaction== | ||
Line 37: | Line 39: | ||
==Treatments== | ==Treatments== | ||
- | Antibiotics are used to treat Cutaneous, if infection spreads and Inhalation Anthrax infections. The primary antibiotics used are Ciprofloxacin and Doxycycline. Antibiotics should be administered before symptoms arise, because it will decrease the fatality rate. In the case of inhalation, treatment should be received within 24 hours because the bacteria can rapidly spread. Treatment includes a 60 day course of antibiotics to ensure all spores have germinated. In some cases more than two antibiotics are administered. <ref>CDC. http://www.bt.cdc.gov/agent/anthrax/faq/treatment.asp</ref>. | + | Antibiotics are used to treat Cutaneous, if infection spreads and Inhalation Anthrax infections. The primary antibiotics used are [[Ciprofloxacin]] and [[Doxycycline]]. Antibiotics should be administered before symptoms arise, because it will decrease the fatality rate. In the case of inhalation, treatment should be received within 24 hours because the bacteria can rapidly spread. Treatment includes a 60 day course of antibiotics to ensure all spores have germinated. In some cases more than two antibiotics are administered. <ref>CDC. http://www.bt.cdc.gov/agent/anthrax/faq/treatment.asp</ref>. |
Current revision
|
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 Collier RJ, Young JA. Anthrax toxin. Annu Rev Cell Dev Biol. 2003;19:45-70. PMID:14570563 doi:10.1146/annurev.cellbio.19.111301.140655
- ↑ Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ CDC. http://www.bt.cdc.gov/agent/anthrax/faq/treatment.asp
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Moayeri M, Leppla SH. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med. 2009 Dec;30(6):439-55. Epub 2009 Jul 26. PMID:19638283 doi:10.1016/j.mam.2009.07.003
- ↑ Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach
- ↑ Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html